MX2015015784A - Metodos para diagnosticar y tratar enfermedad inflamatoria de intestino. - Google Patents

Metodos para diagnosticar y tratar enfermedad inflamatoria de intestino.

Info

Publication number
MX2015015784A
MX2015015784A MX2015015784A MX2015015784A MX2015015784A MX 2015015784 A MX2015015784 A MX 2015015784A MX 2015015784 A MX2015015784 A MX 2015015784A MX 2015015784 A MX2015015784 A MX 2015015784A MX 2015015784 A MX2015015784 A MX 2015015784A
Authority
MX
Mexico
Prior art keywords
methods
inflammatory bowel
disease
diagnosing
bowel disease
Prior art date
Application number
MX2015015784A
Other languages
English (en)
Inventor
A Hackney Jason
Mary Keir
Lilyan Yi Tian Wright
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MX2015015784A publication Critical patent/MX2015015784A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se proporcionan biomarcadores para diagnosticar enfermedad inflamatoria de intestino, incluyendo enfermedad de Crohn, incluyendo enfermedad fibrótica o fibroestenótica de Crohn, y colitis ulcerativa y métodos para usar estos biomarcadores. Además, se proporcionan métodos para tratar trastornos inflamatorios gastrointestinales tal como enfermedades inflamatorias de intestino incluyendo colitis ulcerativa y enfermedad de Crohn, incluyendo enfermedad fibrótica o fibroestenótica de Crohn.
MX2015015784A 2013-05-17 2014-05-16 Metodos para diagnosticar y tratar enfermedad inflamatoria de intestino. MX2015015784A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361824661P 2013-05-17 2013-05-17
PCT/US2014/038434 WO2014186728A2 (en) 2013-05-17 2014-05-16 Methods for diagnosing and treating inflammatory bowel disease

Publications (1)

Publication Number Publication Date
MX2015015784A true MX2015015784A (es) 2016-03-11

Family

ID=51899021

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015015784A MX2015015784A (es) 2013-05-17 2014-05-16 Metodos para diagnosticar y tratar enfermedad inflamatoria de intestino.

Country Status (11)

Country Link
US (1) US20160178644A1 (es)
EP (1) EP2997162A4 (es)
JP (1) JP2016521540A (es)
KR (1) KR20160005044A (es)
CN (1) CN105209643A (es)
BR (1) BR112015028338A2 (es)
CA (1) CA2910199A1 (es)
HK (1) HK1219512A1 (es)
MX (1) MX2015015784A (es)
RU (1) RU2015149032A (es)
WO (1) WO2014186728A2 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016120625A1 (en) 2015-01-29 2016-08-04 Isis Innovation Limited Biomarker
GB201616557D0 (en) * 2016-09-29 2016-11-16 Secretary Of State For Health The Assay for distinguishing between sepsis and systemic inflammatory response syndrome
US11978543B2 (en) 2016-12-14 2024-05-07 Astarte Medical Partners Inc. System and methods for developing and using a microbiome-based action component
CA3047302C (en) * 2016-12-14 2024-01-02 Tracy WARREN System and methods for developing and using a microbiome-based action component for patient health
CN110461356A (zh) * 2016-12-29 2019-11-15 迈阿密大学 用于调节肺中炎性体活性和炎症的方法
US11840565B2 (en) 2016-12-29 2023-12-12 University Of Miami Methods and compositions for treating virus-associated inflammation
EP3654993A4 (en) * 2017-07-17 2021-08-25 The Broad Institute, Inc. CELL ATLAS OF HEALTHY HUMAN COLUMN AND HUMAN COLUMN WITH COLITIS ULCEROSA
EP3655433A4 (en) * 2017-07-18 2021-05-05 Washington University METHODS AND USES OF BIOMARKERS OF INFLAMMATORY INTESTINAL DISEASE
GB201717301D0 (en) * 2017-10-20 2017-12-06 Nordic Bioscience As Type xvi collagen assay
CN111684078B (zh) * 2018-02-12 2024-04-19 豪夫迈·罗氏有限公司 通过评价肿瘤遗传异质性来预测对治疗的应答的方法
EP3818081A4 (en) 2018-07-03 2022-06-22 University of Miami COMPOSITIONS AND METHODS FOR TREATING INFLAMMASOME-RELATED DISEASES OR DISORDERS
WO2020113116A1 (en) * 2018-11-29 2020-06-04 Cedars-Sinai Medical Center Methods of stratifying and treating a sub-population of inflammatory bowel disease patients
WO2020241778A1 (ja) * 2019-05-29 2020-12-03 国立大学法人九州大学 線維化を抑制する医薬組成物
KR102577697B1 (ko) * 2019-11-13 2023-09-14 주식회사 나이벡 염증 및 상처 치료용 펩타이드
EP4162076A4 (en) * 2020-06-03 2024-10-02 Cedars-Sinai Medical Center TREATMENTS FOR A SUBPOPULATION OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
WO2022140667A2 (en) * 2020-12-23 2022-06-30 Icahn School Of Medicine At Mount Sinai Method for treating crohn's disease
WO2023286694A1 (ja) 2021-07-13 2023-01-19 国立大学法人東海国立大学機構 炎症性腸疾患を治療するための医薬組成物
CN120126744B (zh) * 2025-03-05 2026-03-20 中国医学科学院北京协和医院 一种识别肠道罕见病的方法、设备及程序产品
CN120505421B (zh) * 2025-07-18 2025-09-23 宁波大学附属第一医院 一种用于辅助诊断结直肠癌的eRNA分子标记物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005009339A2 (en) * 2003-05-30 2005-02-03 Pathway Diagnostics Corporation, Inc. (a Delaware Corporation) Inflammatory bowel diseases
US20100093552A1 (en) * 2008-10-09 2010-04-15 Asit Panja Use and identification of biomarkers for gastrointestinal diseases
NZ619527A (en) * 2009-04-14 2015-06-26 Nestec Sa Inflammatory bowel disease prognostics
WO2011011339A1 (en) * 2009-07-20 2011-01-27 Genentech, Inc. Gene expression markers for crohn's disease
CN104474546A (zh) * 2010-08-13 2015-04-01 弗·哈夫曼-拉罗切有限公司 用于疾病治疗的针对IL-1β和IL-18的抗体

Also Published As

Publication number Publication date
KR20160005044A (ko) 2016-01-13
EP2997162A4 (en) 2017-02-01
US20160178644A1 (en) 2016-06-23
WO2014186728A3 (en) 2015-01-22
EP2997162A2 (en) 2016-03-23
RU2015149032A (ru) 2017-06-22
CN105209643A (zh) 2015-12-30
WO2014186728A2 (en) 2014-11-20
CA2910199A1 (en) 2014-11-20
JP2016521540A (ja) 2016-07-25
BR112015028338A2 (pt) 2017-07-25
HK1219512A1 (zh) 2017-04-07

Similar Documents

Publication Publication Date Title
MX2015015784A (es) Metodos para diagnosticar y tratar enfermedad inflamatoria de intestino.
MX2022010809A (es) Antagonistas de integrina-beta7 para usarse en el tratamiento y diagnostico de trastornos inflamatorios gastrointestinales.
CA2941917C (en) Methods for the diagnosis and treatment of inflammatory bowel disease
AP2016009549A0 (en) Methods for increasing red blood cell levels and treating sickle-cell disease
IL252796A0 (en) Therapeutic, diagnostic and prognostic methods for bladder cancer
MX2016002879A (es) Sistemas, dispositivos y metodos para la terapia anti-tl1a.
IL246917A0 (en) Biomarker and early diagnosis methods for Alzheimer's disease
MX372664B (es) Un antagonista de integrina beta7 para usarse en diagnosticar y tratar la enfermedad inflamatoria intestinal.
HK1220980A1 (zh) 用於治疗庞贝氏症的方法和组合物
EP2667237A4 (en) DEVICE AND METHOD FOR THE INVESTIGATION, DIAGNOSIS OR DIAGNOSTIC ASSISTANCE AND THERAPY OF FUNCTIONAL VISIBILITY PROBLEMS
EA201890747A1 (ru) Способы лечения воспалительных заболеваний
WO2014205266A3 (en) Compositions and methods for detecting and treating glioblastoma
DK2900279T3 (da) Grpr-antagonister til detektering, diagnose og behandling af grpr-positiv cancer
MA40592A (fr) Compositions et méthodes pour le traitement d'une maladie inflammatoire de l'intestin à l'aide d'une polythérapie à base d'inhibiteurs à petites molécules de récepteur 9 de chimiokine c-c (ccr9) et d'anticorps bloquants anti-intégrine alpha4beta7
WO2014197835A3 (en) Methods and compositions for the treatment of cancer
NZ738100A (en) Igfbp3 and uses thereof
WO2015187727A3 (en) Molecular mammography
SG11201601733VA (en) Diagnosis and treatment of irritable bowel syndrome and inflammatory bowel disease
EP3086846A4 (en) Diagnosing and treating alzheimer's disease
MX2018000528A (es) Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo.
IN2014DN06662A (es)
WO2015013233A3 (en) Methods and compositions for the treatment and diagnosis of bladder cancer
WO2016014992A3 (en) Compositions for treatment, diagnosis and prognosis of diseases
WO2017019673A3 (en) Methods for diagnosing and treating inflammatory bowel disease
WO2013119990A3 (en) Detection and treatment of cd30+ cancers